Your browser doesn't support javascript.
loading
Screening in serum-derived medium reveals differential response to compounds targeting metabolism.
Abbott, Keene L; Ali, Ahmed; Casalena, Dominick; Do, Brian T; Ferreira, Raphael; Cheah, Jaime H; Soule, Christian K; Deik, Amy; Kunchok, Tenzin; Schmidt, Daniel R; Renner, Steffen; Honeder, Sophie E; Wu, Michelle; Chan, Sze Ham; Tseyang, Tenzin; Greaves, Daniel; Hsu, Peggy P; Ng, Christopher W; Zhang, Chelsea J; Farsidjani, Ali; Gramatikov, Iva Monique T; Matheson, Nicholas J; Lewis, Caroline A; Clish, Clary B; Rees, Matthew G; Roth, Jennifer A; Griner, Lesley Mathews; Muir, Alexander; Auld, Douglas S; Heiden, Matthew G Vander.
Afiliação
  • Abbott KL; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Ali A; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Casalena D; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Do BT; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Ferreira R; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Cheah JH; Novartis Institute for BioMedical Research, 181 Massachusetts Avenue, Cambridge, MA 02139, USA.
  • Soule CK; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Deik A; Harvard-MIT Health Sciences and Technology, Cambridge, MA 02139, USA.
  • Kunchok T; Department of Genetics, Harvard Medical School, Boston, MA, USA.
  • Schmidt DR; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Renner S; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Honeder SE; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Wu M; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Chan SH; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Tseyang T; Whitehead Institute for Biomedical Research, Cambridge, MA 02139, USA.
  • Greaves D; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Hsu PP; Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Ng CW; Novartis Institutes for BioMedical Research, 4056 Basel, Switzerland.
  • Zhang CJ; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Farsidjani A; Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
  • Gramatikov IMT; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Matheson NJ; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Lewis CA; Whitehead Institute for Biomedical Research, Cambridge, MA 02139, USA.
  • Clish CB; Whitehead Institute for Biomedical Research, Cambridge, MA 02139, USA.
  • Rees MG; Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge CB2 0AW, UK.
  • Roth JA; Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
  • Griner LM; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • Muir A; Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Auld DS; Massachusetts General Hospital Cancer Center, Boston, MA 02113, USA.
  • Heiden MGV; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
bioRxiv ; 2023 Feb 27.
Article em En | MEDLINE | ID: mdl-36909640

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: BioRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: BioRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos